Newsroom article

11 January 2021 / LYPHE GROUPBack to Newsroom

The Medical Cannabis Clinics hits milestone of 1,500 patients in 2020: 60% market share with an estimated 2,500 patients now in the UK

Despite the challenges and disruptions of the pandemic in 2020, there were successes for the healthcare sector beyond the development of vaccines. Natural alternative medicines in the UK, led by twenty-five prescribing specialist doctors at The Medical Cannabis Clinics (TMCC), have been growing further and further into the mainstream.

TMCC recently surpassed the significant benchmark of consulting and prescribing for over 1,500 patients, for which pharmacy Dispensary Green, owned by LYPHE Group, fulfills almost all medications. As a 60% market share of an estimated total of 2,500 cannabis patients in the UK in 2020, it’s worth looking at a snapshot of this patient database.

Geographics

Demographics

Treatment Areas

This snapshot provides a clear picture of the current state of care in the UK. While there is still plenty to be done in creating a deeper evidence base for the broader application of medical cannabis, TMCC have achieved a great deal over the past 12 months.

At the end of 2019, despite the change in legislation to allow for medical cannabis prescriptions being then a year old, general political and clinical inertia had only created the space for around a few dozen patients to receive treatments.

TMCC has evolved this situation to where we are now which represents a dramatic improvement, and with predictions of up to 15,000 patients in the UK by the end of 2021, we’re looking forward to another year of exponential growth, and expanded and improved care.

 

About LYPHE GROUP:

www.lyphegroup.com

 

LYPHE has built a patient-access ecosystem across the UK (and launching into Europe in 2021) that provides clinics, dispensing, import infrastructure and vital educational services to patients, doctors and the industry. Each operating company shares a central goal to pioneer patient access to safe and effective treatments while normalising cannabis into mainstream healthcare.

 

LYPHE is comprised of the following industry leading companies:

 

Dispensary Green www.dispensarygreen.com

The Medical Cannabis Clinicswww.themedicalcannabisclinics.com

The Academy of Medical Cannabiswww.taomc.org

Astral Healthwww.astral.health

 

About The Medical Cannabis Clinics:

 

The Medical Cannabis Clinics is a telemedicine clinic specialising in innovative cannabis-based medical therapies. TMCC are able to transform lives by giving patients with unmet medical needs access to the life-changing medical cannabis treatment options they so desperately need. www.themedicalcannabisclinics.com